======= SOS2 =======
== Gene Information ==
* **Official Symbol**: SOS2
* **Official Name**: SOS Ras/Rho guanine nucleotide exchange factor 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6655|6655]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q07890|Q07890]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SOS2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOS2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601247|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. [provided by RefSeq, Jul 2016].
* **UniProt Summary**: Promotes the exchange of Ras-bound GDP by GTP. {ECO:0000250|UniProtKB:Q62245}.
|PH|
|RasGEF|
|RasGEF N|
|Histone|
|RhoGEF|
|nucleosome|
|Rho guanyl-nucleotide exchange factor activity|
|positive regulation of small GTPase mediated signal transduction|
|regulation of Rho protein signal transduction|
|regulation of Ras protein signal transduction|
|small GTPase mediated signal transduction|
|regulation of small GTPase mediated signal transduction|
|protein heterodimerization activity|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|positive regulation of cell death|
|positive regulation of intracellular signal transduction|
|G protein-coupled receptor signaling pathway|
|DNA binding|
|regulation of apoptotic process|
|regulation of programmed cell death|
|positive regulation of signal transduction|
|regulation of cell death|
|intracellular signal transduction|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp90|WYE-354 6μM R02 exp90]]|-1.92|
|[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|1.74|
|[[:results:exp99|NFN1 0.4μM R03 exp99]]|1.79|
|[[:results:exp141|Nifurtimox 1μM R03 exp141]]|1.88|
|[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|1.96|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.515|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4228
* **Expression level (log2 read counts)**: 5.15
{{:chemogenomics:nalm6 dist.png?nolink |}}